ChiCTR1800017352
正在进行
右美托咪定
/
右美托咪定
2018-07-25
/
/
麻醉苏醒期躁动
右美托咪定预防儿童骨科手术全身麻醉和局部阻滞苏醒期躁动效果研究
右美托咪定预防儿童骨科手术全身麻醉和局部阻滞苏醒期躁动效果研究
To assess effectiveness of Dexmedetomidine in decreasing if not stopping Emergence Agitation. There are two questions which this study aims to answer 1) Is pain a cause of Emergence Agitation? 2) Is Dexmedetomidine effective in decreasing if not stopping Emergence Agitation?
随机平行对照
其它
Simple Randomization
Not stated
自筹经费
/
50
/
2018-08-01
2019-03-01
/
1. Upper Limb Fractures – Fracture Clavicle, Fracture Humerus, Fracture Radius and/or Ulna, Fracture Carpal Bones; 2. Lower limb Fractures – Fracture Pelvic Bone, Fracture Femur , Fracture Tibia and/or Fibula, Fracture Tarsal Bones; 3. Skin Grafting; 4. Limb and spine deformities noted at birth or later in life (clubfoot, scoliosis, limb length differences); 5. Gait abnormalities (limping); 6. Bone or joint infections and tumors.；
登录查看1. Refusal to participate in the study/Refusal for consent from parents; 2. Known allergy to medications being used; 3. Developmental delay; 4. Mental Retardation; 5. Attention deficit/Hyperactivity Disorder; 6. Use of psychiatric drugs; 7. Liver, Renal, Cardiac and Respiratory Disorders; 8. Spinal Deformity; 9. Local Infection at site of regional block; 10. Bleeding Diathesis; 11. Neurological Deficits.；
登录查看华中科技大学武汉同济医学院
/
全球上市药明康德2024-10-25
药渡2024-10-25
医麦客2024-10-25
小药说药2024-10-25
触界生物2024-10-24
磐霖资本2024-10-24
Pharma CMC2024-10-24
Pharma CMC2024-10-24
瑞博小核酸2024-10-24
君实医学2024-10-24
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
